Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region
about
Population-based epidemiology and microbiology of community-onset bloodstream infectionsEpidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysisMolecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11Characterization and comparison of extended-spectrum β-lactamase (ESBL) resistance genotypes and population structure of Escherichia coli isolated from Franklin's gulls (Leucophaeus pipixcan) and humans in ChileAntimicrobial resistance in hospital-acquired gram-negative bacterial infections.The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.Escherichia coli ST131, an intriguing clonal groupPossibility of CTX-M-14 Gene Transfer from Shigella sonnei to a Commensal Escherichia coli Strain of the Gastroenteritis Microbiome.Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.Molecular features of community-associated extended-spectrum-β-lactamase-producing Escherichia coli strains in the United States.Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceComparison of Extended-Spectrum β-Lactamase (ESBL) CTX-M Genotypes in Franklin Gulls from Canada and ChileAntimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China"Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract"Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, CanadaPhylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countriesCharacteristics of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains Isolated from Multiple Rivers in Southern Taiwan.Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups.Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 yearsExtraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).Escherichia coli sequence type 131: epidemiology and challenges in treatment.Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage.Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry.Phylogenetic groups, extended-spectrum β-lactamases and metallo-β-lactamase in Escherichia coli isolated from fecal samples of patients with diarrhea in Iran.Longitudinal genomic surveillance of multidrug-resistant Escherichia coli carriage in a long-term care facility in the United Kingdom.Increase of widespread A, B1 and D Escherichia coli clones producing a high diversity of CTX-M-types in a Portuguese hospital.Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009.First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice.Multidrug resistance found in extended-spectrum beta-lactamase-producing Enterobacteriaceae from rural water reservoirs in Guantao, China.
P2860
Q27013639-D7C47042-03F6-48B7-B19D-7DEF43B51FCAQ28073332-9FA522BB-7E05-432E-B927-EE892B616B30Q28288964-CB39BD50-1C1F-4E2F-8661-4C9E71EF5145Q28533913-78CD5380-2619-4A4A-993E-2A05042E781FQ30300006-468E4897-14D4-489E-B4C0-D11BE65EB697Q30300020-EB415F55-6AAB-4ECC-B118-C5C7B8BA4B88Q30419770-4A809AF3-9215-4811-A15D-2FB27E83BBA3Q33798233-530D9B80-FF1F-4BD5-A2A3-364115CA9B96Q34057648-59670C2C-3E61-481C-BE95-EEC444D0EED6Q34100513-5C7761E7-D596-44A7-8F51-A437395494FCQ34315040-F5DDF15D-5362-45CF-BF65-836C605B491FQ34596687-A76E7033-9ECC-41D1-A339-5B4125F49F3DQ34777668-520742C6-1ED5-4A67-B053-B71075B85E1EQ35681590-54163A35-C783-473A-8877-BE83FBF30056Q35819191-C89A98C1-A273-4E14-BB5C-1F48F54728B6Q35908410-959F8199-7CF2-41AF-8398-198C7CD0B16AQ35986381-E343BACA-5420-49A2-8D1B-E638F7923FF5Q36086414-48857526-B4AB-4DB6-9ED3-E74381EF3903Q36172185-7A8DD019-335C-472F-9BB6-E35E0134CE68Q36505381-290B0F25-CD03-4341-AD8A-3BDC83840118Q36667293-9E33685F-5DC5-4025-ABC4-5A5B0749D94CQ37001723-CE89DE2C-18FC-4F0D-AF3E-8733ED1AEEE7Q37196254-4790809E-BDEA-461D-9BEA-6439C9707840Q37263765-FEE63AB9-DB7B-4F02-AB39-DD5B26E12397Q37264353-849F7928-7AC4-4A47-98B9-66E948790450Q37504205-14544D58-B9D3-4148-990A-C19FD3375E0CQ37612974-51B69297-B548-404A-B6B6-0D620EA0D009Q37713699-C8D8ECE8-C1F2-4B81-B5EC-273DAD1AB64BQ38063968-3FD7E11C-583A-4496-B579-A3732F4CB8A5Q38074212-DD859FBB-BFB3-45D5-A3EA-512601058EE3Q38201515-D93AAEA6-2F0A-4ACC-92F4-48AB63105B0DQ38848662-D6BA688F-99C8-45C5-B0AF-0186EAE2F07BQ38853303-7196D92C-EEDA-4928-B0CB-AF0E6A673C3DQ38869320-F2F7FD93-7642-4B42-AF58-3C36A7696194Q38922047-25EA899A-B64F-4C7E-937D-5A0FDA4D3FD5Q38990568-EEEF5E78-F723-4CAA-BCA9-9ABBFFAE6ADAQ40190138-FDFA1A48-7FAF-4A8F-8D9B-1798C68B74D1Q40240170-1F0AA11F-791F-4DF8-8B3B-28AF41EA56B0Q40927633-7C05675A-7A5A-435D-B6AE-F22FE9C159E2Q41073121-1B40CFA9-E9FB-41E9-A42F-6CFDDFE70D23
P2860
Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Molecular epidemiology over an ...... a centralized Canadian region
@ast
Molecular epidemiology over an ...... a centralized Canadian region
@en
type
label
Molecular epidemiology over an ...... a centralized Canadian region
@ast
Molecular epidemiology over an ...... a centralized Canadian region
@en
prefLabel
Molecular epidemiology over an ...... a centralized Canadian region
@ast
Molecular epidemiology over an ...... a centralized Canadian region
@en
P2093
P2860
P356
P1476
Molecular epidemiology over an ...... a centralized Canadian region
@en
P2093
Akke K van der Bij
Daniel B Gregson
Gisele Peirano
Johann D D Pitout
P2860
P304
P356
10.1128/JCM.06025-11
P407
P577
2011-12-07T00:00:00Z